triumph 1 retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH- Trial Retatrutide Just Hit The Number

GLP-1 medications have been shown to have anti-inflammatory effects, potentially easing these symptoms

GLP1 medications and microdosing Explain microdosing GLP1 what is it and why would we consider it

The realistic timeline puts MHRA approval at late 2027 to mid 2028, with NHS access through NICE technology appraisal arriving in 2029 at the earliest

The extended-release form of metformin is not approved for pediatric patients

Mounjaro (tirzepatide) GLP-1 + GIP In SURMOUNT-1 (72 weeks), average weight loss at the highest dose was often quoted around: ~22.5% (highest dose) What that looks like: If you start at 100 kg , ~22.5% is about 2223 kg lost on average